Response of anxiety and agitation symptoms during nefazodone treatment of major depression
- Author
- FAWCETT, J1 ; MARCUS, R. N; ANTON, S. F; O'BRIEN, K; SCHWIDERSKI, U
[1] Rush-Presbyterian-St. Luke's medical cent., dep. psychiatry, Chicago IL 60612, United States - Issue title
- Receptor specificity of antidepressants and importance for treatment outcome
- Source
The Journal of clinical psychiatry. 1995, Vol 56, pp 37-42 ; SUP6 ; ref : 18 ref
- ISSN
- 0160-6689
- Scientific domain
- Psychology, psychopathology, psychiatry
- Publisher
- Physicians Postgraduate Press, Memphis, TN
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Agitation Angoisse anxiété Antagoniste Antidépresseur Chimiothérapie Etat dépressif Homme Inhibiteur recapture Néfazodone Psychotrope Récepteur sérotoninergique 5-HT1A Symptomatologie Sérotonine Traitement Trouble humeur
- Keyword (en)
- Agitation Anxiety Antagonist Antidepressant agent Chemotherapy Depression Human Reuptake inhibitor Psychotropic 5-HT1A receptor Symptomatology Serotonin Treatment Mood disorder
- Keyword (es)
- Agitación Angustia ansiedad Antagonista Antidepresor Quimioterapia Estado depresivo Hombre Inhibidor recaptura Psicotropo Receptor serotoninérgico 5-HT1A Sintomatología Serotonina Tratamiento Trastorno humor
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 3664285
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Response of anxiety and agitation symptoms during nefazodone treatment of major depression\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of clinical psychiatry\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. clin. psychiatry\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"56\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"37\";s:8:\"\u0000*\u0000epage\";s:2:\"42\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0160-6689\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FAWCETT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:12:\"MARCUS, R. N\";i:1;s:11:\"ANTON, S. F\";i:2;s:10:\"O'BRIEN, K\";i:3;s:14:\"SCHWIDERSKI, U\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP6\";s:9:\"\u0000*\u0000btitle\";s:76:\"Receptor specificity of antidepressants and importance for treatment outcome\";s:8:\"\u0000*\u0000title\";s:90:\"Response of anxiety and agitation symptoms during nefazodone treatment of major depression\";s:8:\"\u0000*\u0000place\";s:11:\"Memphis, TN\";s:6:\"\u0000*\u0000pub\";s:29:\"Physicians Postgraduate Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Response of anxiety and agitation symptoms during nefazodone treatment of major depression\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of clinical psychiatry\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. clin. psychiatry\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"56\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"37\";s:8:\"\u0000*\u0000epage\";s:2:\"42\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0160-6689\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FAWCETT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:12:\"MARCUS, R. N\";i:1;s:11:\"ANTON, S. F\";i:2;s:10:\"O'BRIEN, K\";i:3;s:14:\"SCHWIDERSKI, U\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP6\";s:9:\"\u0000*\u0000btitle\";s:76:\"Receptor specificity of antidepressants and importance for treatment outcome\";s:8:\"\u0000*\u0000title\";s:90:\"Response of anxiety and agitation symptoms during nefazodone treatment of major depression\";s:8:\"\u0000*\u0000place\";s:11:\"Memphis, TN\";s:6:\"\u0000*\u0000pub\";s:29:\"Physicians Postgraduate Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Response of anxiety and agitation symptoms during nefazodone treatment of major depression\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of clinical psychiatry\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. clin. psychiatry\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"56\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"37\";s:8:\"\u0000*\u0000epage\";s:2:\"42\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0160-6689\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FAWCETT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:12:\"MARCUS, R. N\";i:1;s:11:\"ANTON, S. F\";i:2;s:10:\"O'BRIEN, K\";i:3;s:14:\"SCHWIDERSKI, U\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP6\";s:9:\"\u0000*\u0000btitle\";s:76:\"Receptor specificity of antidepressants and importance for treatment outcome\";s:8:\"\u0000*\u0000title\";s:90:\"Response of anxiety and agitation symptoms during nefazodone treatment of major depression\";s:8:\"\u0000*\u0000place\";s:11:\"Memphis, TN\";s:6:\"\u0000*\u0000pub\";s:29:\"Physicians Postgraduate Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Response of anxiety and agitation symptoms during nefazodone treatment of major depression\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of clinical psychiatry\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. clin. psychiatry\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"56\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"37\";s:8:\"\u0000*\u0000epage\";s:2:\"42\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0160-6689\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FAWCETT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:12:\"MARCUS, R. N\";i:1;s:11:\"ANTON, S. F\";i:2;s:10:\"O'BRIEN, K\";i:3;s:14:\"SCHWIDERSKI, U\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP6\";s:9:\"\u0000*\u0000btitle\";s:76:\"Receptor specificity of antidepressants and importance for treatment outcome\";s:8:\"\u0000*\u0000title\";s:90:\"Response of anxiety and agitation symptoms during nefazodone treatment of major depression\";s:8:\"\u0000*\u0000place\";s:11:\"Memphis, TN\";s:6:\"\u0000*\u0000pub\";s:29:\"Physicians Postgraduate Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
